Please login to the form below
Teprotumumab
This page shows the latest Teprotumumab news and features for those working in and with pharma, biotech and healthcare.
FDA approves Horizon's thyroid eye disease drug ahead of schedule
The US Food and Drug Administration (FDA) was due to deliver a verdict on Tepezza (teprotumumab-trbw) on 8 March. ... We believe teprotumumab may impact underlying mechanisms of fibrosis and could demonstrate utility beyond thyroid eye disease,
Latest news
-
Horizon looks bright as FDA panel backs eye drug teprotumumab
took intravenous teprotumumab meeting the primary endpoint of a 2mm reduction in eyeball protrusion, compared to 9.5% of the control arm. ... Teprotumumab has breakthrough therapy, orphan drug and fast track designations from the FDA.
-
Horizon sunny as thyroid eye disease drug hits the mark
Eye specialist Raymond Douglas of Cedars-Sinai Medical Centre in the US, one of the principal investigators in the trial, said that the reduction in proptosis with teprotumumab was “unprecedented”. ... If approved, teprotumumab would give physicians
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
European biotech: a new generation of leaders emerges
Another of its partners, Horizon Therapeutics recently submitted to the FDA the Genmab-developed teprotumumab for the treatment of active thyroid eye disease.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Presenting Outstanding Outcomes from HCP Education in Multiple Myeloma at IMS in Athens
- Top 10 benefits of virtual advisory boards: Save Time and Resources
- NIHR launches new framework to highlight health progress outcomes
- Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
- UKHSA secures UK-based vaccine deal for future influenza pandemics
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
No results were found
PMHub
The Good Ideas Group
Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
